Ascendis Pharma A/S Current Financial Assets
Ascendis Pharma A/S (ASND) had Current Financial Assets of EUR 766.09 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:CurrentFinancialAssets · last filed 2026-02-11
- 2025-12-31: Current Financial Assets 766.09M EUR.
- 2025-09-30: Current Financial Assets 677.64M EUR.
- 2025-06-30: Current Financial Assets 606.21M EUR.
- 2025-03-31: Current Financial Assets 586.45M EUR.
| Period end | Current Financial Assets |
|---|---|
| 2025-12-31 | 766.09M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 677.64M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 606.21M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 586.45M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 727.47M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 665.45M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 310.74M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 364.05M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 437.10M EUR 20-F · filed 2025-02-12 |
| 2023-03-31 | 608.34M EUR 6-K · filed 2023-04-27 |
| 2022-12-31 | 749.33M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 928.32M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 961.00M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 990.78M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 694.73M EUR 20-F · filed 2023-02-16 |